{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:42:58Z","timestamp":1778154178025,"version":"3.51.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Diabetic ketoacidosis is the most severe metabolic derangement due to prolonged insulin deficiency as in type 1 diabetes. Diabetic ketoacidosis, a life-threatening condition, is often diagnosed late. A timely diagnosis is mandatory to prevent its consequences, mainly neurological. The COVID-19 pandemic and lockdown have reduced the availability of medical care and access to hospitals. The aim of our retrospective study was to compare the frequency of ketoacidosis at the diagnosis of type 1 diabetes between the lockdown-post lockdown period and the previous two calendar years, in order to evaluate the impact of the COVID-19 pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p>We retrospectively assessed the clinical and metabolic data at\u00a0the diagnosis of type 1 diabetes in children in the Liguria Region during 3 different time\u00a0periods: calendar year 2018 (Period A), calendar year 2019 until February 23,2020 (Period B) and from February 24, 2020 onwards to March 31, 2021 (Period C).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We analyzed 99 patients with newly-diagnosed T1DM from 01\/01\/2018 to 31\/03\/2021. Briefly, a younger age at diagnosis of T1DM was observed in Period 2 compared to Period 1 (p = 0.03). The frequency of DKA at clinical onset of T1DM was similar in Period A (32.3%) and Period B (37.5%), while it significantly increased in Period C (61.1%) compared to Period B (37.5%) (p = 0.03). PH values were similar in Period A (7.29 \u00b1 0.14) and Period B (7.27 \u00b1 0.17), while they were significantly lower in Period C (7.21 \u00b1 0.17) compared to Period B (p = 0.04).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>An increase in the frequency of diabetic ketoacidosis has been documented in newly diagnosed pediatric patients in the Liguria Region during and after the lockdown period compared to previous calendar years. This increase could have been caused by the delay in diagnosis following the restrictions imposed by the lockdown with consequently reduced access to health care facilities. More information on the risks of ketoacidosis is desirable by means of social and medical awareness campaigns.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcdhc.2022.846827","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:51:28Z","timestamp":1645685488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Increased Frequency of Diabetic Ketoacidosis: The Link With COVID-19 Pandemic"],"prefix":"10.3389","volume":"3","author":[{"given":"Giuseppe","family":"d\u2019Annunzio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Lucia","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilea","family":"Lezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Minuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Calevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Gaiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Fichera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Borea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","unstructured":"Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-Ncov). World Health Organization (WHO) (Press Release). 30th January 2020. Archived From the Original on 31st January 2020. Retrieved 30th January 20202005"},{"key":"B2","unstructured":"WHO Director-General\u2019s Opening Remarks at the Briefingon COVID-19 \u2013 11th March 2020. World Health Organization (WHO) (Press Release). 11th March 2020. Achieved From the Original on 11th March 2020. Retrieved12th March 2020"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 Diabetes","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4942-x","article-title":"Early-Life Factors Contributing to Type 1 Diabetes","volume":"62","author":"Craig","year":"2019","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3075","article-title":"Incidence and Trend of Type 1 Diabetes and the Underlying Environmental Determinants","volume":"35","author":"Ying","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00078","article-title":"The Role of Gutmicrobiotaand Environmental Factors in Type 1 Diabetespathogenesis","author":"Dedrick","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 Diabetes","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2018-0231.PMID:31371634","article-title":"Diabetic Ketoacidosis","volume":"40","author":"Cashen","year":"2019","journal-title":"Pediatr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2012.0161","article-title":"Morbidity and Mortality of Diabeticketoacidosis With and Without Insulin Pump Care","volume":"14","author":"Realsen","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.12.015","article-title":"Patient Characteristics Associated With Differences in Admission Frequency for Diabetic Ketoacidosis in United States Children\u2019s Hospitals","volume":"171","author":"Malik","year":"2016","journal-title":"J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12701","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic Ketoacidosis and the Hyperglycemic Hyperosmolar State","author":"Wolfsdorf","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05152-1","article-title":"Temporal Trends in Diabetic Ketoacidosis at Diagnosis of Paediatric Type 1 Diabetes Between 2006 and 2016: Results From 13 Countries in Three Continents","volume":"63","author":"Cherubini","year":"2020","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00592-016-0909-2","article-title":"Type 1 Diabetes in Sardinia: Facts and Hypotheses in the Context of Worldwide Epidemiological Data","volume":"54","author":"Songini","year":"2017","journal-title":"Acta Diabetol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-316903","article-title":"Diabetic Ketoacidosis at the Onset of Disease During a National Awareness Campaign: A 2-Year Observational Study in Children Aged 0-18 Years","volume":"105","author":"Rabbone","year":"2020","journal-title":"Arch Dis Child"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.01.057","article-title":"Is the Risk of Diabetic Ketoacidosis Modifiable","volume":"171","author":"Garibaldi","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.23750\/abm.v89i1.6936","article-title":"Diabetic Ketoacidosis at the Onset of Type 1 Diabetes in Young Children: Is It Time to Launch a Tailored Campaign for DKA Prevention in Children <5 Years","author":"Iovane","year":"2018","journal-title":"Acta BioMed"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.575020","article-title":"Socioeconomic Inequalities Increase the Probability of Ketoacidosis at Diagnosis of Type 1 Diabetes: A 2014-2016 Nationwide Study of 2,679 Italian Children","author":"Gesuita","year":"2020","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1321","article-title":"Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children","volume":"43","author":"Rabbone","year":"2020","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.13445","article-title":"Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany","volume-title":"JAMA","author":"Kamrath","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1633","article-title":"Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany","volume":"43","author":"Tittel","year":"2020","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000884","article-title":"Presentation of Newly Diagnosed Type 1 Diabetes in Children and Young People During COVID-19: A National UK Survey","author":"Ng","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5114\/pedm.2020.101003","article-title":"Increased Frequency of Severe Diabetic Ketoacidosis at Type 1 Diabetes Onset Among Children During COVID-19 Pandemic Lockdown: An Observational Cohort Study","volume":"26","author":"D\u017cyga\u0142o","year":"2020","journal-title":"Pediatr. Endocrinol Diabetes Metab"},{"key":"B23","volume-title":"Legge Regionale 27 Agosto 2013, N. 27. Norme Per La Prevenzione, La Diagnosi E La Cura Del Diabete Mellito (Bollettino Ufficiale N. 14, Del 14.08.2013)","year":"2013"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30108-5","article-title":"Delayed Access or Provision of Care in Italy Resulting From COVID-19","volume":"4","author":"Lazzerini","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2020-000742","article-title":"Italian COVID-19 Epidemic: Effects on Paediatric Emergency Attendance-A Survey in the Emilia Romagna Region","author":"Cella","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2260","article-title":"COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic\u2019s Impact in Type 1 and Type 2 Diabetes","volume":"44","author":"Gregory","year":"2021","journal-title":"Diabetes Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2020033","DOI":"10.23750\/abm.v91i3.10366","article-title":"COVID-19 and Type 1 Diabetes: Concerns and Challenges","author":"Iughetti","year":"2020","journal-title":"Acta BioMed"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108372","article-title":"Caring for Children and Adolescents With Type 1 Diabetes Mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) Statements During COVID-19 Pandemia","volume":"168","author":"d\u2019Annunzio","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12563","article-title":"Transglutaminase Antibodies and Celiacdisease in Children With Type 1 Diabetes and in Their Family Members","volume":"19","author":"Parkkola","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2335.PMID:28388722","article-title":"Thyroid and Islet Autoantibodies Predict Autoimmunethyroid Diseaseat Type 1 Diabetes Diagnosis","author":"Jonsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2022.846827\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:51:33Z","timestamp":1645685493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2022.846827\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":30,"alternative-id":["10.3389\/fcdhc.2022.846827"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2022.846827","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"846827"}}